Literature DB >> 30952633

Long Noncoding RNA ELIT-1 Acts as a Smad3 Cofactor to Facilitate TGFβ/Smad Signaling and Promote Epithelial-Mesenchymal Transition.

Satoshi Sakai1,2, Tatsuya Ohhata1, Kyoko Kitagawa1, Chiharu Uchida3, Takuya Aoshima4, Hiroyuki Niida1, Tetsuro Suzuki2, Yasumichi Inoue5, Keiji Miyazawa6, Masatoshi Kitagawa7,4.   

Abstract

TGFβ is involved in various biological processes, including development, differentiation, growth regulation, and epithelial-mesenchymal transition (EMT). In TGFβ/Smad signaling, receptor-activated Smad complexes activate or repress their target gene promoters. Smad cofactors are a group of Smad-binding proteins that promote recruitment of Smad complexes to these promoters. Long noncoding RNAs (lncRNA), which behave as Smad cofactors, have thus far not been identified. Here, we characterize a novel lncRNA EMT-associated lncRNA induced by TGFβ1 (ELIT-1). ELIT-1 was induced by TGFβ stimulation via the TGFβ/Smad pathway in TGFβ-responsive cell lines. ELIT-1 depletion abrogated TGFβ-mediated EMT progression and expression of TGFβ target genes including Snail, a transcription factor critical for EMT. A positive correlation between high expression of ELIT-1 and poor prognosis in patients with lung adenocarcinoma and gastric cancer suggests that ELIT-1 may be useful as a prognostic and therapeutic target. RIP assays revealed that ELIT-1 bound to Smad3, but not Smad2. In conjunction with Smad3, ELIT-1 enhanced Smad-responsive promoter activities by recruiting Smad3 to the promoters of its target genes including Snail, other TGFβ target genes, and ELIT-1 itself. Collectively, these data show that ELIT-1 is a novel trans-acting lncRNA that forms a positive feedback loop to enhance TGFβ/Smad3 signaling and promote EMT progression. SIGNIFICANCE: This study identifies a novel lncRNA ELIT-1 and characterizes its role as a positive regulator of TGFβ/Smad3 signaling and EMT.Graphical Abstract: http://cancerres.aacrjournals.org/content/canres/79/11/2821/F1.large.jpg. ©2019 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30952633     DOI: 10.1158/0008-5472.CAN-18-3210

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  42 in total

1.  New twists on long noncoding RNAs: from mobile elements to motile cancer cells.

Authors:  Tuan M Nguyen; Sumayya Alchalabi; Adewunmi Oluwatoyosi; Ali S Ropri; Jason I Herschkowitz; Jeffrey M Rosen
Journal:  RNA Biol       Date:  2020-06-10       Impact factor: 4.652

2.  Mechanism of long noncoding RNAs as transcriptional regulators in cancer.

Authors:  Yan Huang; Qi Guo; Xi-Ping Ding; Xiangting Wang
Journal:  RNA Biol       Date:  2020-01-10       Impact factor: 4.652

3.  Multi-omic profiling of peritoneal metastases in gastric cancer identifies molecular subtypes and therapeutic vulnerabilities.

Authors:  Yosuke Tanaka; Fumiko Chiwaki; Shinya Kojima; Masahito Kawazu; Masayuki Komatsu; Toshihide Ueno; Satoshi Inoue; Shigeki Sekine; Keisuke Matsusaki; Hiromichi Matsushita; Narikazu Boku; Yae Kanai; Yasushi Yatabe; Hiroki Sasaki; Hiroyuki Mano
Journal:  Nat Cancer       Date:  2021-08-16

4.  Long non-coding RNA SMASR inhibits the EMT by negatively regulating TGF-β/Smad signaling pathway in lung cancer.

Authors:  Lele Xu; Wenzhong Liu; Tongtong Li; Yuying Hu; Yu Wang; Lijie Huang; Yan Wang; Shujuan Shao; Xuefeng Liu; Qimin Zhan
Journal:  Oncogene       Date:  2021-04-30       Impact factor: 9.867

5.  ELK1‑mediated upregulation of lncRNA LBX2‑AS1 facilitates cell proliferation and invasion via regulating miR‑491‑5p/S100A11 axis in colorectal cancer.

Authors:  Gang Ma; Weijie Dai; Juan Zhang; Qianjun Li; Biao Gu; Yaqi Song; Xiaozhong Yang
Journal:  Int J Mol Med       Date:  2021-06-03       Impact factor: 4.101

6.  LncPSCA in the 8q24.3 risk locus drives gastric cancer through destabilizing DDX5.

Authors:  Yan Zheng; Tianshui Lei; Guangfu Jin; Haiyang Guo; Nasha Zhang; Jie Chai; Mengyu Xie; Yeyang Xu; Tianpei Wang; Jiandong Liu; Yue Shen; Yemei Song; Bowen Wang; Jinming Yu; Ming Yang
Journal:  EMBO Rep       Date:  2021-09-02       Impact factor: 8.807

7.  Tumor suppressor lnc-CTSLP4 inhibits EMT and metastasis of gastric cancer by attenuating HNRNPAB-dependent Snail transcription.

Authors:  Tao Pan; Zhenjia Yu; Zhijian Jin; Xiongyan Wu; Airong Wu; Junyi Hou; Xinyu Chang; Zhiyuan Fan; Jianfang Li; Beiqin Yu; Fangyuan Li; Chao Yan; Zhongyin Yang; Zhenggang Zhu; Bingya Liu; Liping Su
Journal:  Mol Ther Nucleic Acids       Date:  2021-02-10       Impact factor: 8.886

8.  Colorectal Cancer-Associated Smad4 R361 Hotspot Mutations Boost Wnt/β-Catenin Signaling through Enhanced Smad4-LEF1 Binding.

Authors:  Claudia B Lanauze; Priyanka Sehgal; Katharina Hayer; Manuel Torres-Diz; James A Pippin; Struan F A Grant; Andrei Thomas-Tikhonenko
Journal:  Mol Cancer Res       Date:  2021-02-19       Impact factor: 6.333

9.  LINC00941 promotes CRC metastasis through preventing SMAD4 protein degradation and activating the TGF-β/SMAD2/3 signaling pathway.

Authors:  Nan Wu; Mingzuo Jiang; Haiming Liu; Yi Chu; Dan Wang; Jiayi Cao; Zhiyang Wang; Xin Xie; Yuying Han; Bing Xu
Journal:  Cell Death Differ       Date:  2020-07-31       Impact factor: 15.828

Review 10.  Molecular Pathogenesis of Pulmonary Fibrosis, with Focus on Pathways Related to TGF-β and the Ubiquitin-Proteasome Pathway.

Authors:  Naoki Inui; Satoshi Sakai; Masatoshi Kitagawa
Journal:  Int J Mol Sci       Date:  2021-06-05       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.